Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
16.90
-1.18 (-6.53%)
At close: Jun 5, 2026, 4:00 PM EDT
16.57
-0.33 (-1.95%)
After-hours: Jun 5, 2026, 5:30 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.7 billion as of June 5, 2026. Its market cap has increased by 90.22% in one year.
Market Cap
2.70B
Enterprise Value
2.68B
1-Year Change
90.22%
Ranking
Category
Stock Price
$16.90
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.70B, a decrease of -43.35%. That is a compound annual growth rate of -7.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 2.89B | 16.71% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BillionToOne | 4.52B |
| Twist Bioscience | 4.50B |
| Sotera Health Company | 4.35B |
| RadNet | 4.08B |
| Veracyte | 3.89B |
| GRAIL | 2.62B |
| GeneDx Holdings | 1.57B |
| NeoGenomics | 1.32B |